Steroid withdrawal and donor-specific hyporeactivity after cadaveric renal allotransplantation on maintenance triple therapy

Nephrology Dialysis Transplantation

Volumn 12, Issue 9, 1997, Pages 1949-1955

  Beik, A I ^a,b   Higgins, R M ^a   Lam, F T ^a   Morris, A G ^b  

^a WALSGRAVE HOSPITAL   (United Kingdom)

^b UNIVERSITY OF WARWICK   (United Kingdom)

Author keywords

Donor specific hyporeactivity; Limiting dilution analysis; Renal transplantation; Steroid withdrawal; T helper lymphocytes

Indexed keywords

AZATHIOPRINE; CREATININE; CYCLOSPORIN; IMMUNOSUPPRESSIVE AGENT; PREDNISOLONE; STEROID;

ADULT; AGED; ALLOTRANSPLANTATION; ARTICLE; CADAVER KIDNEY; CLINICAL ARTICLE; CREATININE BLOOD LEVEL; DRUG WITHDRAWAL; FEMALE; HELPER CELL; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; KIDNEY TRANSPLANTATION; MALE; PRIORITY JOURNAL; RECIPIENT;

ADULT; AGED; CADAVER; CELL COUNT; FEMALE; HUMANS; IMMUNOSUPPRESSIVE AGENTS; KIDNEY; KIDNEY TRANSPLANTATION; MALE; MIDDLE AGED; POSTOPERATIVE CARE; STEROIDS; T-LYMPHOCYTES, HELPER-INDUCER; TISSUE DONORS; TRANSPLANTATION, HOMOLOGOUS;

EID: 0030769612     PISSN: 09310509     EISSN: None     Source Type: Journal    
DOI: 10.1093/ndt/12.9.1949     Document Type: Article

References (23)

1. Frei D, Keusch G, Hugentobler M et al. Withdrawal of steroids after cadaveric kidney allotransplantation on maintenance triple therapy. Transplant Proc 1989; 21: 1620-1622
2. Stratta R, Armbrust M, Oh C et al. Withdrawal of steroid immunosuppression in renal transplant recipients. Transplantation 1988; 45: 323-328
3. Ratcliffe PJ, Dudley CRK, Higgins RM, Firth JD, Smith B, Morris PJ. Randomised controlled trial of steroid withdrawal in renal transplant recipients receiving triple immunosuppression. Lancet 1996; 348: 643-664
4. Oncevski A, Rostoker G, Buisson C et al. Is long-term triple drug therapy required for maintaining kidney allograft tolerance? Effect of azathioprine withdrawal at three months posttransplantation. Transplant Proc 1989; 21: 1625-1626
5. Kupin W, Venkat K, Oh H. Steroid withdrawal in cyclosporine-treated living related donor renal transplant recipients. Transplant Proc 1989; 21: 1623-1624
6. Goulmy E, Bittner K, Blokland E et al. Renal transplant patients with steroid withdrawal evaluated longitudinally for their donor-specific cytotoxic T cell reactivity. Transplantation 1991; 52: 1083-1085
7. Ingulli E, Sharma V, Singh A, Suthanthiran M, Tejani A. Steroid withdrawal, rejection and the mixed lymphocyte reaction in children after renal transplantation. Kidneuy Int 1993; 44 [Suppl. 43]: S36-39
8. Schulak J, Mayes J, Moritz C, Hricik D. A prospective randomised trial of prednisone versus no prednisone maintenance therapy in cyclosporine-treated and azathioprine- treated renal transplant patients. Transplantation 1990; 49: 327-332
9. Kahan B, Kerman R, Van Buren C, Flechner S, Golden D, Lewis R. Clinical outcome in 36 patients after at least one and up to 5 years of steroid withdrawal based upon specific mixed lymphocyte reaction hyporesponsiveness toward the living related donor. Transplant Proc 1989; 21: 1579-1580
10. Hariharan S, First M, Penn I et al. Prednisone withdrawal in HLA-identical living related donor transplant recipients. Transplant Proc 1989; 21: 1617-1619
11. Hricik D, Whalen C, Lautman J et al. Withdrawal of steroids after renal transplantation-clinical predictors of outcome. Transplantation 1992; 53: 41-45
12. Ghobrial I, Morris A, Booth L. Clinical significance of in vitro donor specific hyporesponsiveness in renal allograft recipients as demonstrated by the MLR. Transplant Int 1994; 7: 420-427
13. Solez K, Axelsen R, Benediktsson H et al. International standardisation of criteria for the histologic diagnosis of renal allograft rejection: The Banff working classification of kidney transplant pathology. Kidney Int 1993; 44: 411-422
14. Orosz C, Adams P, Ferguson R. Frequency of human alloantigen-reactive T lymphocytes: II. method for limiting dilution analysis of alloantigen-reactive helper T cells in human peripheral blood. Transplantation 1987; 43: 718-724
15. Deacock S, Schwarer A, Batchelor R, Goldman J, Lechler R. A rapid limiting dilution assay for measuring frequencies of alloreactive, interleukin-2-producing T cells in humans. J Immunol Methods 1992; 147: 83-92
16. Taswell C. Limiting dilution assays for the determination of immunocompetent cell frequencies: I. data analysis. J Immunol 1981; 126: 1614-1619
17. Strijbosch L, Does R, Buurman W. Computer aided design and evaluation of limiting and serial dilution experiments. Int J Biomed Comput 1988; 23: 279-290
18. Hricik DE, Almawi WY, Strom TB. Trends in the use of glucocorticoids in renal transplantation. Transplantation 1994; 57: 979-989
19. Hall B. Cells mediating allograft rejection. Transplantation 1991; 51: 1141-1151
20. Bishop D, Shelby J, Eichwald E. Mobilization of T lymphocytes following cardiac transplantation. Transplantation 1992; 53: 849-857
21. Sharrock C, Kaminski E, Man S. Limiting dilution analysis of human T cells: a useful clinical tool, Immunol Today 1990; 11: 281-286
22. Flechner S, Kerman R, Van Buren C, Epps L, Kahan B. The use of cyclosporine in living-related renal transplantation: donor-specific hyporesponsiveness and steroid withdrawal. Transplantation 1984; 38: 685-691
23. Reinsmoen N, Matas A. Evidence that improved late renal transplant outcome correlates with the development of in vitro donor antigen-specific hyporeactivity. Transplantation 1993; 55: 1017-1023